STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
1
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · no price filed
What the filings say about CMRF
Insiders, 180 days
+$2.6M net bought
1 buyer · 1 seller · 0% of sales under a 10b5-1 plan
Activist stakes (13D), 180 days
1 filing
Largest: 100.0% of the class
CIM insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CIM GROUP, INC. insiders bought a net $2.6M of stock across 2 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 111.8% of the 19,157 shares held after it.
No other insider sold within 30 days.
1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Schreiber Jason K sold about $110.1K of CMRF on Sep 4, 2026, the largest insider sale at the company on our record; 1 fund added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 60.7% of the 868,172 shares held after it.
No other insider bought within 30 days.
1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO & President RESSLER RICHARD S bought about $2.7M of CMRF on Sep 4, 2026, the largest insider purchase at the company on our record; 1 fund added in the latest 13F quarter.
2 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
The record shows a net $2.6M bought by insiders over 180 days, 1 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Revenue, TTM CMRF
FY Dec 2025
n/a
FY Dec 2024
$483.9M
FY Dec 2023
$568.9M
FY Dec 2022
$452.1M
FY Dec 2021
$365.7M
Jun 2026
$111.0M
Mar 2026
$97.6M
Dec 2025
$97.9M
Sep 2025
$104.5M
Jun 2025
$135.9M
Mar 2025
$106.4M
Dec 2024
$106.2M
Sep 2024
$121.4M
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM CMRF
FY Dec 2025
n/a
FY Dec 2024
-60.4%
FY Dec 2023
+4.9%
FY Dec 2022
+31.8%
FY Dec 2021
+23.6%
Jun 2026
-27.1%
Mar 2026
+44.1%
Dec 2025
+30.4%
Sep 2025
+29.0%
Jun 2025
+0.0%
Mar 2025
-30.9%
Dec 2024
-14.4%
Sep 2024
+6.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM CMRF
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
5.30x
LongTermDebt as filed 2026-06-30 (includes the current portion); equity 2026-06-30
Debt to equity CMRF
FY Dec 2025
0.53x
FY Dec 2024
1.79x
FY Dec 2023
1.73x
FY Dec 2022
1.80x
FY Dec 2021
1.64x
Jun 2026
5.30x
Mar 2026
1.56x
Dec 2025
0.53x
Sep 2025
1.69x
Jun 2025
1.72x
Mar 2025
1.77x
Dec 2024
1.79x
Sep 2024
1.77x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.04x
TTM operating cash flow over LongTermDebt as filed 2026-06-30 (includes the current portion)
Cash flow to debt CMRF
FY Dec 2025
0.41x
FY Dec 2024
0.05x
FY Dec 2023
0.06x
FY Dec 2022
0.04x
FY Dec 2021
0.04x
Jun 2026
0.04x
Mar 2026
0.05x
Dec 2025
0.41x
Sep 2025
0.04x
Jun 2025
0.03x
Mar 2025
0.05x
Dec 2024
0.05x
Sep 2024
0.06x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on equity CMRF
FY Dec 2025
n/a
FY Dec 2024
-14.5%
FY Dec 2023
+1.2%
FY Dec 2022
+5.8%
FY Dec 2021
+3.7%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
-1.0%
Jun 2025
-2.2%
Mar 2025
-14.5%
Dec 2024
-14.5%
Sep 2024
-15.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on assets CMRF
FY Dec 2025
n/a
FY Dec 2024
-5.0%
FY Dec 2023
+0.4%
FY Dec 2022
+2.0%
FY Dec 2021
+1.5%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
-0.3%
Jun 2025
-0.7%
Mar 2025
-5.0%
Dec 2024
-5.0%
Sep 2024
-5.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CMRF
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CMRF
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
13.82x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CMRF
FY Dec 2025
21.25x
FY Dec 2024
n/a
FY Dec 2023
0.02x
FY Dec 2022
0.00x
FY Dec 2021
n/a
Jun 2026
11.51x
Mar 2026
8.33x
Dec 2025
21.25x
Sep 2025
0.12x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$3.8B
market value at close 2026-10-23 on 2026-08-11 shares, plus LongTermDebt as filed 2026-06-30 (includes the current portion), minus cash 2026-06-30
Enterprise value CMRF
FY Dec 2025
$1.4B
FY Dec 2024
$3.0B
FY Dec 2023
$3.7B
FY Dec 2022
$4.3B
FY Dec 2021
n/a
Jun 2026
$3.6B
Mar 2026
$3.6B
Dec 2025
$1.4B
Sep 2025
$2.7B
Jun 2025
$3.0B
Mar 2025
$3.0B
Dec 2024
$3.0B
Sep 2024
$3.1B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield CMRF
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing CMRF
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
0.00x
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CMRF ranks highest on risk and compliance (91st percentile) and insider conviction (74th), and lowest on growth (11th), among Real Estate peers.
Financial health
20
Inputs
Debt to equity5.30x · 8 pct, sector of 210
Cash flow to debt0.04x · 32 pct, sector of 215
Growth
11
Inputs
Revenue growth, YoY-14.0% · 11 pct, sector of 244
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
74
Inputs
Net Form 4 buying (codes P and S), 180d$2.6M · 96 pct, sector of 156
Insider buyers, 180d1 · 51 pct, sector of 158
Risk and compliance
91
Inputs
Short interest, % of floatno short interest or no free float on file
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+3.0% · 91 pct, sector of 212
3 not measured: Profitability, Institutional and government, US patents
Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of operating income; the filed year and its quarters do not reconcile, so the trailing figure is withheld
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CMRF filings, in plain words
Are CIM insiders buying or selling CMRF?
In the 180 days to 2026-10-27, CIM insiders were net buyers, a net $2.6M: $2.7M of purchases and $110.1K of sales reported on Form 4, by 1 buyer and 1 seller.
Read the full summary
In the 180 days to 2026-10-27, CIM insiders were net buyers of CMRF, a net $2.6M across purchases and sales reported on Form 4 by 1 buyer and 1 seller. Most of that figure, $2.7M, came from a holder of 10% or more rather than an officer or director. Purchases outweighed sales more than tenfold by value. 1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 100.0% of the class. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.